These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28224137)

  • 1. HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).
    Gougeon ML; Poirier-Beaudouin B; Durant J; Lebrun-Frenay C; Saïdi H; Seffer V; Ticchioni M; Chanalet S; Carsenti H; Harvey-Langton A; Laffon M; Cottalorda J; Pradier C; Dellamonica P; Vassallo M
    Heliyon; 2017 Feb; 3(2):e00245. PubMed ID: 28224137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alarmins and central nervous system inflammation in HIV-associated neurological disorders.
    Gougeon ML
    J Intern Med; 2017 May; 281(5):433-447. PubMed ID: 27862491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.
    Letendre SL; Zheng JC; Kaul M; Yiannoutsos CT; Ellis RJ; Taylor MJ; Marquie-Beck J; Navia B;
    J Neurovirol; 2011 Feb; 17(1):63-9. PubMed ID: 21246320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.
    Yuan L; Qiao L; Wei F; Yin J; Liu L; Ji Y; Smith D; Li N; Chen D
    J Neurovirol; 2013 Apr; 19(2):144-9. PubMed ID: 23389619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
    Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
    Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
    Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
    J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
    Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
    J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
    Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
    PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
    Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.
    Yuan L; Liu A; Qiao L; Sheng B; Xu M; Li W; Chen D
    Biomed Res Int; 2015; 2015():506872. PubMed ID: 25821806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
    Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
    Yiannoutsos CT; Nakas CT; Navia BA;
    Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid.
    Grauer OM; Reichelt D; Grüneberg U; Lohmann H; Schneider-Hohendorf T; Schulte-Mecklenbeck A; Gross CC; Meuth SG; Wiendl H; Husstedt IW
    Ann Clin Transl Neurol; 2015 Sep; 2(9):906-19. PubMed ID: 26401512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical neurons are a prominent source of the proinflammatory cytokine osteopontin in HIV-associated neurocognitive disorders.
    Silva K; Hope-Lucas C; White T; Hairston TK; Rameau T; Brown A
    J Neurovirol; 2015 Apr; 21(2):174-85. PubMed ID: 25636782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2 on Peripheral Blood CD14
    Veenstra M; Byrd DA; Inglese M; Buyukturkoglu K; Williams DW; Fleysher L; Li M; Gama L; León-Rivera R; Calderon TM; Clements JE; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):120-133. PubMed ID: 29981000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk.
    Saïdi H; Melki MT; Gougeon ML
    PLoS One; 2008; 3(10):e3601. PubMed ID: 18974890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered metabolism in right basal ganglia associated with asymptomatic neurocognitive impairment in HIV-infected individuals.
    Zhan Y; Cai DC; Liu Y; Song F; Shan F; Song P; Chen G; Zhang Y; Wang H; Shi Y
    Heliyon; 2024 Jan; 10(1):e23342. PubMed ID: 38169709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.